A Vitamin B12 lip filler is a dermal filler that combines hyaluronic acid (HA) with Vitamin B12 (cobalamin). The B12 provides anti-inflammatory, DNA-synthesis-stimulating, and tissue-regeneration properties that traditional HA-only fillers lack.
CEHISHU is a leading example, containing 0.1% B12 (900 pg/ml) and 20mg/ml fractionated-molecular-weight HA. It is designed specifically for the lip mucosa and perioral region.
CEHISHU Medical produces CEHISHU Lip Filler Gel, a Vitamin B12-enriched HA filler manufactured in a GMP-certified, ISO 13485 facility in China. It is CE-marked and exported to over 40 countries.
Most major filler brands (Juvederm by Allergan, Restylane by Galderma, Belotero by Merz) do not currently offer B12-enriched formulations, making CEHISHU one of the few options in this niche category.
Vitamin B12 (cobalamin) plays an integral role in DNA synthesis and acts as a cofactor in numerous biochemical processes. In dermal fillers, B12:
B12 deficiency is associated with skin conditions including acne, psoriasis, hyperpigmentation, atopic dermatitis, and vitiligo — underscoring its essential role in skin health.
Fractionated-molecular-weight HA is a blend of HA chains with different molecular weights. CEHISHU uses a range from 2600 KD (high molecular weight) to 50 KD (low molecular weight).
| Molecular Weight | Function |
|---|---|
| High MW (2600 KD) | Surface plumping, volume definition |
| Medium MW | Mid-dermis hydration |
| Low MW (50 KD) | Deep tissue penetration, cellular stimulation |
CEHISHU uses a mechanical stabilization process under nitrogen pressure, rather than chemical cross-linking agents like BDDE (1,4-butanediol diglycidyl ether) used in most traditional HA fillers.
Advantages of mechanical stabilization:
Clinical evaluation documented measurable volumetric improvement:
| Case | Before | After | Increase |
|---|---|---|---|
| Case A | 1.0 cm | 1.35 cm | +35% |
| Case B | 1.6 cm | 1.9 cm | +19% |
Individual results vary by patient anatomy, tissue condition, and adherence to protocol.
Based on degree of tissue aging, CEHISHU is administered in 4-6 sessions at 20/30-day intervals. After completing the initial cycle, maintenance sessions are performed every 2 months to optimize and prolong results.
The gel is injected into the dermal-submucosal plane of the lip mucosa and perioral region by licensed medical professionals.
CEHISHU is injected into the dermal-submucosal plane of the lip mucosa. Safe injection requires understanding of the superior and inferior labial artery distribution.
Use of a micro-cannula is recommended to minimize vascular risk. Only licensed medical professionals with aesthetic injection training should perform the procedure.
| Feature | CEHISHU | Juvederm |
|---|---|---|
| Active ingredients | HA + Vitamin B12 | HA only |
| HA molecular weight | Fractionated (2600-50 KD) | Single MW |
| Stabilization | Mechanical (N₂ pressure) | Chemical (BDDE) |
| B12 tissue stimulation | Yes | No |
| OEM/ODM available | Yes | No |
Contraindications include:
Potential adverse effects are transient: local edema, erythema, and tenderness typically resolving within 24-72 hours.
CEHISHU is available to licensed aesthetic clinics, medical distributors, and importers with medical device import authorization. Wholesale pricing is provided on request based on volume and territory.
Inquiries can be submitted via the CEHISHU Medical contact form.
Yes. CEHISHU Medical offers OEM/ODM manufacturing on its B12+HA platform with three tiers:
| Tier | MOQ | Features |
|---|---|---|
| Starter OEM | 1,000 | Standard formula, logo on packaging |
| Brand Builder | 5,000 | Adjusted HA/B12, custom packaging |
| Exclusive Partner | 20,000+ | Proprietary blend, exclusive territory |
The company provides full regulatory dossier support including CE documentation and FDA registration assistance. See OEM services page for details.
Our medical aesthetics team is ready to answer technical, clinical, or commercial questions.
Contact Our Team